People news: Astellas' Agensys and Bausch & Lomb

Share this article:
Astellas Pharma's Agensys subsidiary named Allergan's Sef Kurstjens CEO and president, replacing founder Donald Rice, who is retiring. Kurstjens, MD, PhD, was SVP, chief medical officer and head of global drug development at Allergan. Agensys is developing a pipeline of fully human monoclonal antibodies to treat solid tumor cancers.

Bausch & Lomb named Mariano Garcia-Valiño president, Latin America. Valiño was most recently an operating partner at global private equity firm Advent International, focusing on investment opportunities in Latin American pharma, and worked at Pfizer from 2001 to 2009, having headed the company's largest operating group in Brazil and led integration of Latin American operations during the Pfizer-Pharmacia merger.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media